🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 22 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 29/11/2004 | 26,64 | 26,81 | 26,38 | 26,40 | -0,11% | 1,61% | 13.866.717 |
| 26/11/2004 | 26,11 | 26,50 | 26,10 | 26,43 | +1,76% | 1,54% | 7.689.281 |
| 24/11/2004 | 26,00 | 26,15 | 25,87 | 25,97 | +0,30% | 1,06% | 12.081.344 |
| 23/11/2004 | 25,89 | 25,96 | 25,75 | 25,90 | +0,04% | 0,81% | 12.102.304 |
| 22/11/2004 | 25,88 | 26,15 | 25,75 | 25,89 | +0,04% | 1,51% | 13.626.515 |
| 19/11/2004 | 25,95 | 26,19 | 25,76 | 25,88 | -0,88% | 1,65% | 14.523.813 |
| 18/11/2004 | 26,02 | 26,24 | 25,65 | 26,11 | +0,07% | 2,27% | 14.841.462 |
| 17/11/2004 | 26,38 | 26,53 | 26,05 | 26,09 | -0,51% | 1,81% | 14.607.234 |
| 16/11/2004 | 26,00 | 26,48 | 25,96 | 26,22 | +1,44% | 1,98% | 20.989.239 |
| 15/11/2004 | 25,24 | 26,09 | 25,19 | 25,85 | +2,42% | 3,55% | 25.266.756 |
| 12/11/2004 | 25,00 | 25,45 | 25,00 | 25,24 | +1,15% | 1,79% | 19.452.242 |
| 11/11/2004 | 25,33 | 25,38 | 24,92 | 24,95 | -0,98% | 1,81% | 20.317.576 |
| 10/11/2004 | 24,43 | 25,64 | 24,43 | 25,20 | +1,58% | 4,96% | 35.614.498 |
| 09/11/2004 | 24,65 | 24,99 | 24,56 | 24,81 | -2,15% | 1,74% | 45.119.858 |
| 08/11/2004 | 24,89 | 25,36 | 24,56 | 25,35 | +1,37% | 3,22% | 37.632.946 |
| 05/11/2004 | 25,46 | 25,67 | 24,80 | 25,01 | -3,00% | 3,41% | 52.761.874 |
| 04/11/2004 | 26,66 | 26,96 | 25,65 | 25,78 | -3,05% | 4,90% | 35.970.085 |
| 03/11/2004 | 26,34 | 26,62 | 25,67 | 26,59 | +3,99% | 3,62% | 51.887.842 |
| 02/11/2004 | 26,95 | 27,24 | 25,19 | 25,57 | -5,23% | 7,61% | 67.250.684 |
| 01/11/2004 | 28,00 | 28,44 | 26,71 | 26,98 | -9,68% | 6,17% | 69.787.997 |
| 29/10/2004 | 30,07 | 30,57 | 29,63 | 29,88 | -0,82% | 3,14% | 17.765.382 |
| 28/10/2004 | 29,72 | 30,22 | 29,69 | 30,12 | +1,12% | 1,77% | 10.244.095 |
| 27/10/2004 | 29,15 | 29,81 | 29,11 | 29,79 | +1,83% | 2,39% | 12.499.915 |
| 26/10/2004 | 29,08 | 29,26 | 28,85 | 29,26 | +0,56% | 1,41% | 13.229.009 |
| 25/10/2004 | 29,16 | 29,23 | 28,82 | 29,09 | -0,23% | 1,41% | 11.498.342 |
| 22/10/2004 | 29,68 | 29,82 | 29,10 | 29,16 | -2,24% | 2,41% | 14.164.034 |
| 21/10/2004 | 29,84 | 30,06 | 29,30 | 29,83 | -0,45% | 2,53% | 10.728.690 |
| 20/10/2004 | 29,73 | 30,04 | 29,68 | 29,96 | +0,77% | 1,22% | 16.312.120 |
| 19/10/2004 | 29,68 | 29,87 | 29,61 | 29,73 | +0,84% | 0,87% | 15.273.447 |
| 18/10/2004 | 28,91 | 29,59 | 28,91 | 29,48 | +1,31% | 2,34% | 13.306.456 |